NYSE:KVUE Kenvue Q1 2026 Earnings Report $17.33 +0.18 (+1.03%) Closing price 03:59 PM EasternExtended Trading$17.27 -0.06 (-0.34%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Kenvue EPS ResultsActual EPS$0.32Consensus EPS $0.27Beat/MissBeat by +$0.05One Year Ago EPS$0.24Kenvue Revenue ResultsActual Revenue$3.91 billionExpected Revenue$3.84 billionBeat/MissBeat by +$64.10 millionYoY Revenue Growth+4.50%Kenvue Announcement DetailsQuarterQ1 2026Date5/7/2026TimeBefore Market OpensConference Call DateThursday, May 7, 2026Conference Call Time9:30AM ETUpcoming EarningsKenvue's Q2 2026 earnings is estimated for Thursday, August 6, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Kenvue Earnings HeadlinesKenvue Inc. (NYSE:KVUE) Given Consensus Rating of "Hold" by AnalystsMay 14, 2026 | americanbankingnews.comIs It Time To Reconsider Kenvue (KVUE) After Its Recent Share Price WeaknessMay 11, 2026 | finance.yahoo.comI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.May 20 at 1:00 AM | Porter & Company (Ad)How The Kenvue (KVUE) Story Is Shifting Around Q4 Results And US$19 Valuation TargetsMay 11, 2026 | finance.yahoo.comKenvue: Q1 Earnings SnapshotMay 7, 2026 | finance.yahoo.com5 Things to Know Before the Stock Market OpensMay 7, 2026 | investopedia.comSee More Kenvue Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Kenvue? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kenvue and other key companies, straight to your email. Email Address About KenvueKenvue (NYSE:KVUE) is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines. The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels. Its product mix spans skincare and cosmetics, toiletries and oral hygiene, baby and family care products, adhesive and wound care, and OTC analgesics and remedies. Kenvue sells finished consumer products through traditional brick‑and‑mortar retailers, pharmacies and increasingly through e‑commerce and direct‑to‑consumer channels. Kenvue was formed as part of a corporate separation from Johnson & Johnson in 2023 and operates as an independent public company headquartered in the United States. It maintains a global presence, serving markets across North America, Europe, Asia and other regions through regional sales networks and international distribution partners. The company’s leadership team is drawn from executives with experience in consumer health and brand management; Thibaut Mongon has served as chief executive following the separation. As a consumer health-focused business, Kenvue emphasizes brand building, research and development for consumer‑facing products, and the optimization of supply‑chain and go‑to‑market capabilities. Its strategic priorities include innovation in product formulations and packaging, expanding digital and retail distribution, and leveraging consumer insights to support growth across established and emerging markets.View Kenvue ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Analog Devices Provides Much-Needed Pullback: How Low Can It Go?USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal LoomsFrom Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 OutlookMirum Pharma: A Rare Disease Growth Story to WatchArhaus Stock Drops to 52-Week Low After Q1 EarningsWhy Home Depot’s Sell-Off Could Become a Huge OpportunityPalo Alto Networks Up 70%: Can the Rally Last Into June? Upcoming Earnings NetEase (5/21/2026)Ross Stores (5/21/2026)Walmart (5/21/2026)Deere & Company (5/21/2026)Mitsubishi UFJ Financial Group (5/21/2026)AutoZone (5/26/2026)Marvell Technology (5/27/2026)PDD (5/27/2026)Synopsys (5/27/2026)Bank Of Montreal (5/27/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
